Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Galectin Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Galectin Therapeutics Inc. December 3, 202598.5%
-
Galectin Therapeutics Inc. January 23, 202596.7%
-
Galectin Therapeutics Inc. December 7, 202396.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 23, 2025 | Galectin Therapeutics Inc. | Open-market purchase | +5,500 | $3.55 | $19,525 |
| Jul 17, 2025 | Galectin Therapeutics Inc. | Open-market purchase | +5,000 | $2.90 | $14,500 |
| Dec 24, 2024 | Galectin Therapeutics Inc. | Open-market purchase | +10,000 | $0.81 | $8,100 |
| Oct 17, 2024 | Galectin Therapeutics Inc. | Open-market purchase | +1,300 | $2.64 | $3,432 |
| Oct 16, 2024 | Galectin Therapeutics Inc. | Open-market purchase | +5,000 | $2.70 | $13,500 |
| Oct 16, 2024 | Galectin Therapeutics Inc. | Open-market purchase | +5,000 | $2.70 | $13,500 |
| Jun 20, 2024 | Galectin Therapeutics Inc. | Open-market purchase | +2,500 | $2.38 | $5,950 |
| Apr 22, 2024 | Galectin Therapeutics Inc. | Open-market purchase | +2,500 | $2.98 | $7,450 |
| Apr 9, 2024 | Galectin Therapeutics Inc. | Inheritance | +2,063 | — | — |
Questions about Kevin D. Freeman
What boards is Kevin D. Freeman on?
Kevin D. Freeman sits on the board of Galectin Therapeutics Inc.
How long has Kevin D. Freeman served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.